PATENT CLAIM ANALYSIS

Application Number: 15924039
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "001100"]

Abstract:
A method for treatment of prostate cancer or benign prostate hyperplasia by combination therapy comprising administering to a patient an androgen-deprivation therapy agent and a bacteriochlorophyll derivative followed by photodynamic therapy (PDT) or vascular-targeted photodynamic therapy (VTP).

Claim (Index 8):
The method of  claim 7 , wherein the Bchl-D has the formula I: wherein\n M represents 2H or Pd; \n R 1  is O\u2014R 4  or \u2014NHR 5 , wherein R 4  is selected from the group consisting of H, H + , an ammonium group or a monovalent metal cation, and R 5  is an RGD-containing peptide or RGD peptidomimetic residue; \n R 2  is \u2014O\u2014C 1 -C 6  alkyl; \n R 3  is \u2014NH\u2014(CH 2 ) n -SO 3 \u2212 R 6 + , wherein n is 2 or 3, and R 6 +  is a monovalent metal cation and \n pharmaceutically acceptable salts and optical isomers thereof.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 90.0
- Lexical Diversity: 1.3125
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12920088', '14115217', '13447825', '14412235', '15331777']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8049463956474531
- 35 USC 102 Novelty (BERT): 0.5277872001098338
- Combined Prediction Score: 0.7772304760936911
- Mean Citation Score: 297.153702
- Max Citation Score: 347.8857
- Similarity Product: 240.7147075169742

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test